US2008103211A1PendingUtilityA1

Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina

57
Assignee: COLLIER JR ROBERT JPriority: Nov 30, 1999Filed: Jan 4, 2008Published: May 1, 2008
Est. expiryNov 30, 2019(expired)· nominal 20-yr term from priority
Inventors:Robert J. CollierLouis Desantis, Jr.Michael A. Kapin
A61P 43/00A61K 31/138A61K 31/222A61K 31/34A61K 31/343A61K 31/165A61K 31/5377A61K 31/4704A61P 27/02A61K 31/404
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions and methods for treating disorders of the outer retina with β-adrenoceptor antagonists are disclosed.

Claims

exact text as granted — not AI-modified
1 - 6 . (canceled)  
     
     
         7 . An ophthalmic composition for treating disorders of the outer retina, said composition comprising from 0.001% to 5% w/v of a β-adrenoceptor antagonist in a pharmaceutical acceptable carrier.  
     
     
         8 . The composition of  claim 7 , wherein the concentration of the β-adrenoceptor antagonist is from 0.01% to 2% w/v.  
     
     
         9 . The composition of  claim 8 , wherein the concentration of the β-adrenoceptor antagonist is from 0.25% to 0.75% w/v.  
     
     
         10 . The composition of  claim 7 , further comprising poly(styrene divinylbenzene) Sulfonic Acid.  
     
     
         11 . The composition of  claim 10 , wherein the β-adrenoceptor antagonist is levobetaxolol.

Join the waitlist — get patent alerts

Track US2008103211A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.